Gilead Sciences, Inc. to Pay $202 Million to Resolve Kickback Allegations on HIV/AIDs Drugs

Gilead Sciences, Inc. to Pay $202 Million to Resolve Kickback Allegations on HIV/AIDs Drugs

(Anchorage, AK) – The State of Alaska has joined with other states and the federal government to reach an agreement with Gilead Sciences, Inc. (“Gilead”) to settle allegations that the company paid kickbacks to providers to improperly promote its HIV drugs: Stribild®, Genvoya®, Complera®, Odefsey®, Descovy®, and Biktarvy® (the “Gilead HIV Drugs”). “Kickback schemes drain Medicaid […]